We report a case of amiodarone-induced epididymitis and review the pertinent literature. This disease is currently a diagnosis of exclusion and is believed to be self-limiting. We found new evidence for the pathological diagnosis and identified amiodarone-like crystals in the epididymis as a pathological mechanism of this disease. This case also suggests that amiodarone-induced epididymitis is not self-limiting. Continued use of amiodarone according to the current guidelines led to a bilateral epididymectomy. We recommend withdrawal or reduction of amiodarone dosage immediately once the signs and symptoms of epididymitis present in this population of patients. When epididymitis does not seem to be caused by an infection or any other identifiable etiology, this should not be overlooked by the cardiologist, urologist or general practitioner. These findings and recommendations should help reduce the suffering of patients and improve their clinical outcomes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000361038 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gynaecomastia Revealing Amiodarone-Induced Hypergonadotropic Hypogonadism: An Overlooked Complication?
Eur J Case Rep Intern Med
October 2024
Department of Endocrinology, CHU UCL Namur - Site Godinne, Université Catholique de Louvain, Yvoir, Belgium.
Article Synopsis
- A case study discusses primary hypogonadism caused by prolonged use of amiodarone, a medication known for multiple side effects.
- The patient, a 57-year-old man, experienced testicular pain, gynaecomastia, and decreased libido, ultimately diagnosed with hypergonadotropic hypogonadism and confirmed testicular atrophy.
- The findings emphasize the need for careful monitoring of patients on amiodarone to detect signs of testicular dysfunction early, ensuring appropriate treatment for hypogonadism.
Amiodarone-Induced Epididymitis: A Case Report and Review of the Literature.
Cureus
June 2024
Summit Internal Medicine, Grandview Medical Center, Birmingham, USA.
Amiodarone is commonly used to prevent and treat life-threatening cardiac arrhythmias. However, it is also known to have an extensive side effect profile. A rare adverse effect of amiodarone is epididymitis.
View Article and Find Full Text PDFAmiodarone induced epididymo-orchitis.
Urol Case Rep
September 2019
Internal Medicine, Cardiovascular Disease, Cooper Cardiology, 900 Centennial Boulevard, Building 2, Voorhees, NJ, 08043, USA.
Unlabelled: Amiodarone has a well-established and extensive side effect profile: pulmonary fibrosis, thyroid toxicity, corneal deposits, and skin discoloration. However, in some rare instances epididymitis/orchitis is a side effect of amiodarone. Symptoms range from testicular pain to swelling and erythema.
View Article and Find Full Text PDFAmiodarone-induced epididymitis: a pathologically confirmed case report and review of the literature.
Cardiology
February 2015
Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health; Department of Cardiology, Qilu Hospital, Shandong University, Jinan, China.
We report a case of amiodarone-induced epididymitis and review the pertinent literature. This disease is currently a diagnosis of exclusion and is believed to be self-limiting. We found new evidence for the pathological diagnosis and identified amiodarone-like crystals in the epididymis as a pathological mechanism of this disease.
View Article and Find Full Text PDFAmiodarone induced epididymitis: a case report.
Iran Red Crescent Med J
January 2014
Department of Cardiology, Baskent University Faculty of Medicine, Ankara, Turkey.
Introduction: Amiodarone is an effective drug for life-threatening arrhythmias like recurrent ventricular fibrillation and atrial fibrillation. Amiodarone creates rarely genitourinary side effects are seen. These are epididymitis, testicular dysfunction and impotance.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!